Insecticides (India) Ltd submits Q2/H1 FY27 investor presentation, reporting FY23–FY26 EBITDA margin expansion to 10.6%
- Gross profit margin rose from 23.1% to 31.5%; EBITDA margin increased from 6.8% to 10.6% over FY23–FY26.
- ROCE improved from 10.4% to 16.1%, while ROE rose from 6.9% to 11.4%.
- Presentation covers product launches, distribution, manufacturing, R&D and collaborations; it provides no Q2/H1 revenue, operating margin or net profit figures.
